Home Companies Antares Therapeutics COMPANY
Clinical Phase 2
6 open jobs · last seen Oct 23, 2026 · 2 sources
Keywords: small molecule oncology precision oncology cancer ATX-898
Location: Boston, MA · source · May 15, 2025
Profile checked Oct 10, 2026
Hiring Title Location (from posting) Employer posted First seen Sr. Director/Vice President, Clinical Development (Immunology) San Francisco, CA Sep 29, 2026 Oct 9, 2026 Scientist II/Sr. Scientist I, Immunology San Francisco, CA Sep 28, 2026 Oct 9, 2026 Sr. ScientistII/Principal Scientist, Chemical Biology Boston, MA Sep 16, 2026 Oct 9, 2026 Sr. Scientist I/Sr. Scientist II, Applied AI & Agentic Systems for Drug Discovery Boston, MA Aug 20, 2026 Oct 9, 2026 Scientist II/Sr. Scientist I, In-Vivo Pharmacology (Must Have Immunology Experience) Boston, MA Jul 2, 2026 Oct 9, 2026
See all 6 jobs
At a glance HQ Boston, MA source Stage Clinical Phase 2 Latest trial Phase 1/Phase 2: A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors (Aug 1, 2026) source Trial and FDA signals New trial + clinical hiring Started a Phase 1/2 trial (NCT07767474, actual start Aug 31, 2026); since then posted 1 clinical-operations role. ClinicalTrials.gov NCT07767474 (Aug 31, 2026)Evidence (1 event) Aug 31, 2026 · ClinicalTrials.gov NCT07767474 leadSponsor.name='Antares Therapeutics, Inc'; phases=['PHASE1', 'PHASE2']; overallStatus=RECRUITING; startDateStruct={date:2026-08-31,type:ACTUAL}; studyFirstPostDate=2026-08-17; briefTitle='A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors' Job counts as of Oct 18, 2026. All trial and FDA signals
Timeline Oct 9, 2026 Board tracked Radar started tracking this company’s job board (6 open jobs at last check). source ↗ Aug 1, 2026 Trial start Phase 1/Phase 2: A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors source ↗ Upcoming milestones Oct 28, 2028 (ESTIMATED) · Phase 1/Phase 2 · A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors · NCT07767474 Estimated primary completion per ClinicalTrials.gov. Dates move.
Open jobs 6 Title Location (from posting, not HQ) Employer posted First seen Level Sr. Director/Vice President, Clinical Development (Immunology) San Francisco, CA Sep 29, 2026 Oct 9, 2026 Executive Description Scientist II/Sr. Scientist I, Immunology San Francisco, CA Sep 28, 2026 Oct 9, 2026 Mid Description Sr. ScientistII/Principal Scientist, Chemical Biology Boston, MA Sep 16, 2026 Oct 9, 2026 Senior Description Sr. Scientist I/Sr. Scientist II, Applied AI & Agentic Systems for Drug Discovery Boston, MA Aug 20, 2026 Oct 9, 2026 Mid Description Scientist II/Sr. Scientist I, In-Vivo Pharmacology (Must Have Immunology Experience) Boston, MA Jul 2, 2026 Oct 9, 2026 Mid Description Sr. Scientist/Principal Scientist, Translational Research and Clinical Biomarkers (Immunology) Boston, MA Jun 12, 2026 Oct 9, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Clinical trials (lead sponsor) 1 Record Title Phase Status Start Primary completion NCT07767474 A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors Phase 1/Phase 2 Not yet recruiting Aug 1, 2026 Oct 28, 2028 (estimated)
Raises and investors new Form D raises come from the company’s own SEC filing (last 2 years).
Investor Listed in the portfolio of Atlas Venture (captured Oct 12, 2026). portfolio page ↗ Connect See your connections at Antares Therapeutics on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-18
